The latest closing stock price for Telomir Pharmaceuticals as of November 22, 2024 is 4.24.
An investor who bought $1,000 worth of Telomir Pharmaceuticals stock at the IPO in 2024 would have $-152 today, roughly 0 times their original investment - a -15.20% compound annual growth rate over 1 years.
The all-time high Telomir Pharmaceuticals stock closing price was 11.90 on February 14, 2024.
The Telomir Pharmaceuticals 52-week high stock price is 20.72, which is 388.7% above the current share price.
The Telomir Pharmaceuticals 52-week low stock price is 3.11, which is 26.7% below the current share price.
The average Telomir Pharmaceuticals stock price for the last 52 weeks is 5.70.
An investor who bought $1,000 worth of Telomir Pharmaceuticals stock at the IPO in 2024 would have $-152 today, roughly 0 times their original investment - a -15.20% compound annual growth rate over 1 years.
The all-time high Telomir Pharmaceuticals stock closing price was 11.90 on February 14, 2024.
The Telomir Pharmaceuticals 52-week high stock price is 20.72, which is 388.7% above the current share price.
The Telomir Pharmaceuticals 52-week low stock price is 3.11, which is 26.7% below the current share price.
The average Telomir Pharmaceuticals stock price for the last 52 weeks is 5.70.